Photo of Keara Redmond

Keara Redmond

Dr

  • Room 03.006 - CCRCB

    United Kingdom

20102019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 7 Article
  • 4 Conference contribution
Filter
Conference contribution
2015

The role of micro-environment-derived ligands in resistance to EGFR monoclonal antibodies in KRAS wild type colorectal cancer

Weir, J-A., Redmond, K., Bradley, C. & Van Schaeybroeck, S., Nov 2015, The role of micro-environment-derived ligands in resistance to EGFR monoclonal antibodies in KRAS wild type colorectal cancer. National Cancer Research Institute, Vol. A87.

Research output: Chapter in Book/Report/Conference proceedingConference contribution

2014

The Role of the c-MET/HGF Signalling Axis as a Critical Regulator of Invasion and Migration in Colorectal Cancer

Bradley, C., Dunne, P., Redmond, K., McArt, D., Arthur, K., McQuaid, S., Blayney, J., Salto-Tellez, M., Johnston, P. & Van Schaeybroeck, S., Nov 2014, The Role of the c-MET/HGF Signalling Axis as a Critical Regulator of Invasion and Migration in Colorectal Cancer. National Cancer Research Institute

Research output: Chapter in Book/Report/Conference proceedingConference contribution

The role of the inflammatory microenvironment in regulating invasion, migration and drug responses in colorectal cancer

Redmond, K., Dunne, P., Forsythe, N., Longley, D., Johnston, P. & Van Schaeybroeck, S., Nov 2014, The role of the inflammatory microenvironment in regulating invasion, migration and drug responses in colorectal cancer. National Cancer Research Institute

Research output: Chapter in Book/Report/Conference proceedingConference contribution

2013

Oncogenic Kras and p53 mutational status control chemotherapy-induced growth factor shedding via activation of ADAM17 in colorectal cancer

Redmond, K., Dunne, P., McArt, D., Longley, D., Johnston, P. & Van Schaeybroeck, S., Nov 2013, Oncogenic Kras and p53 mutational status control chemotherapy-induced growth factor shedding via activation of ADAM17 in colorectal cancer. National Cancer Research Institute

Research output: Chapter in Book/Report/Conference proceedingConference contribution